CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
NCT06957028
This study is recruiting at 8 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly detect and manage high blood sugar in pregnant women, early in pregnancy. The main questions it aims to answer are: (1) any problems for the baby, such as being too large for their age, shoulder injuries (like broken bones), high bilirubin levels needing light treatment, low blood sugar, or needing to stay in the NICU; (2) any high blood pressure issues for the mother during pregnancy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Gestational Diabetes Mellitus in Pregnancy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Jaeb Center for Health Research
- Last updated on ClinicalTrials.gov
- December 23, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama at Birmingham · Birmingham, AL
Florida · 1
- University of Miami · Miami, FL
Georgia · 1
- Emory University · Decatur, GA
Minnesota · 1
- IDC at Park Nicollet · Saint Louis Park, MN
New York · 1
- Icahn School of Medicine at Mount Sinai · New York, NY
Ohio · 1
- Cleveland Clinic · Cleveland, OH
Oregon · 1
- Oregon Health & Science University · Portland, OR
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.